These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Divided doses for methadone maintenance. Adinoff B Am J Psychiatry; 2008 Mar; 165(3):303-5. PubMed ID: 18316426 [No Abstract] [Full Text] [Related]
7. Methadone:effective analgesia, confusion, and risk. Lipman AG J Pain Palliat Care Pharmacother; 2005; 19(2):3-5. PubMed ID: 16061455 [No Abstract] [Full Text] [Related]
8. Ultra-low dose oral naltrexone decreases side effects and potentiates the effect of methadone. Cruciani RA; Lussier D; Miller-Saultz D; Arbuck DM J Pain Symptom Manage; 2003 Jun; 25(6):491-4. PubMed ID: 12782427 [No Abstract] [Full Text] [Related]
9. Very-high-dose methadone with minimal toxicity and inadequate pain control in a hospice patient with cancer. Latuga NM; Wahler RG J Pain Palliat Care Pharmacother; 2013 Jun; 27(2):143-9. PubMed ID: 23646910 [TBL] [Abstract][Full Text] [Related]
10. Parenteral methadone: an essential medication for the treatment of pain. Manfredi PL; Foley KM; Payne R; Houde R; Inturrisi CE J Pain Symptom Manage; 2003 Aug; 26(2):687-8. PubMed ID: 12906950 [No Abstract] [Full Text] [Related]
11. Intravenous methadone for cancer pain unrelieved by morphine and hydromorphone: clinical observations. Manfredi PL; Borsook D; Chandler SW; Payne R Pain; 1997 Mar; 70(1):99-101. PubMed ID: 9106815 [TBL] [Abstract][Full Text] [Related]
12. Rotation to methadone after opioid dose escalation: How should individualization of dosing occur? Zimmermann C; Seccareccia D; Booth CM; Cottrell W J Pain Palliat Care Pharmacother; 2005; 19(2):25-31. PubMed ID: 16061458 [TBL] [Abstract][Full Text] [Related]
13. Use of methadone for uncontrolled pain: an alternative dosing regimen. Walmsley R; Robson P; Lee MA J Pain Symptom Manage; 2010 Dec; 40(6):e3-4. PubMed ID: 20965690 [No Abstract] [Full Text] [Related]
14. Methadone for cancer pain: what have we learned from clinical studies? Soares LG Am J Hosp Palliat Care; 2005; 22(3):223-7. PubMed ID: 15909785 [TBL] [Abstract][Full Text] [Related]
15. Transitioning a cancer patient from high-dose intravenous hydromorphone therapy to intravenous methadone. LeBaron V; Brody J; Lee EM; Hardin C; Snyder L J Pain Palliat Care Pharmacother; 2011; 25(4):356-61. PubMed ID: 22126165 [No Abstract] [Full Text] [Related]
16. Methadone: friend or foe? Jackson WC Tenn Med; 2011 Apr; 104(4):39-41. PubMed ID: 21560909 [No Abstract] [Full Text] [Related]
19. Methadone: does stigma play a role as a barrier to treatment of chronic pain? Shah S; Diwan S Pain Physician; 2010; 13(3):289-93. PubMed ID: 20495594 [TBL] [Abstract][Full Text] [Related]